[1]
“Drug therapy problem in the pharmacotherapeutic follow-up of patients with tuberculosis, HIV/AIDS and in co-infection: integrative review”, RSD, vol. 11, no. 4, p. e1211427424, Mar. 2022, doi: 10.33448/rsd-v11i4.27424.